AU2002952086A0 - Treatment of osteoarthritis - Google Patents

Treatment of osteoarthritis

Info

Publication number
AU2002952086A0
AU2002952086A0 AU2002952086A AU2002952086A AU2002952086A0 AU 2002952086 A0 AU2002952086 A0 AU 2002952086A0 AU 2002952086 A AU2002952086 A AU 2002952086A AU 2002952086 A AU2002952086 A AU 2002952086A AU 2002952086 A0 AU2002952086 A0 AU 2002952086A0
Authority
AU
Australia
Prior art keywords
osteoarthritis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002952086A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Queensland UQ
Original Assignee
University of Queensland UQ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Queensland UQ filed Critical University of Queensland UQ
Priority to AU2002952086A priority Critical patent/AU2002952086A0/en
Publication of AU2002952086A0 publication Critical patent/AU2002952086A0/en
Priority to US10/531,560 priority patent/US7659246B2/en
Priority to JP2004543826A priority patent/JP2006505555A/ja
Priority to PCT/AU2003/001373 priority patent/WO2004035079A1/en
Priority to CA002542513A priority patent/CA2542513A1/en
Priority to AU2003269609A priority patent/AU2003269609B2/en
Priority to EP03750172A priority patent/EP1575606A4/en
Priority to US12/703,178 priority patent/US20100267639A1/en
Priority to JP2011170931A priority patent/JP2011241224A/ja
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AU2002952086A 2002-10-16 2002-10-16 Treatment of osteoarthritis Abandoned AU2002952086A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
AU2002952086A AU2002952086A0 (en) 2002-10-16 2002-10-16 Treatment of osteoarthritis
US10/531,560 US7659246B2 (en) 2002-10-16 2003-10-15 Treatment of osteoarthritis
JP2004543826A JP2006505555A (ja) 2002-10-16 2003-10-16 骨関節症の治療
PCT/AU2003/001373 WO2004035079A1 (en) 2002-10-16 2003-10-16 Treatment of osteoarthritis
CA002542513A CA2542513A1 (en) 2002-10-16 2003-10-16 Treatment of osteoarthritis
AU2003269609A AU2003269609B2 (en) 2002-10-16 2003-10-16 Treatment of osteoarthritis
EP03750172A EP1575606A4 (en) 2002-10-16 2003-10-16 TREATMENT OF OSTEOARTHRITIS
US12/703,178 US20100267639A1 (en) 2002-10-16 2010-02-09 Treatment of osteoarthritis
JP2011170931A JP2011241224A (ja) 2002-10-16 2011-08-04 骨関節症の治療

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2002952086A AU2002952086A0 (en) 2002-10-16 2002-10-16 Treatment of osteoarthritis

Publications (1)

Publication Number Publication Date
AU2002952086A0 true AU2002952086A0 (en) 2002-11-07

Family

ID=28795579

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002952086A Abandoned AU2002952086A0 (en) 2002-10-16 2002-10-16 Treatment of osteoarthritis
AU2003269609A Ceased AU2003269609B2 (en) 2002-10-16 2003-10-16 Treatment of osteoarthritis

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2003269609A Ceased AU2003269609B2 (en) 2002-10-16 2003-10-16 Treatment of osteoarthritis

Country Status (6)

Country Link
US (2) US7659246B2 (enExample)
EP (1) EP1575606A4 (enExample)
JP (2) JP2006505555A (enExample)
AU (2) AU2002952086A0 (enExample)
CA (1) CA2542513A1 (enExample)
WO (1) WO2004035079A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO755097A0 (en) * 1997-06-25 1997-07-17 University Of Queensland, The Receptor agonist and antagonist
AUPS160602A0 (en) * 2002-04-08 2002-05-16 University Of Queensland, The Therapeutic method
AU2002952086A0 (en) * 2002-10-16 2002-11-07 The University Of Queensland Treatment of osteoarthritis
CA2542507C (en) * 2002-10-16 2013-04-16 The University Of Queensland Treatment of inflammatory bowel disease
EP1498422A1 (de) * 2003-07-17 2005-01-19 Jerini AG C5a-Rezeptor-Antagonisten
EP2155904A2 (en) * 2007-05-01 2010-02-24 Hill's Pet Nutrition Inc. Methods and compositions for diagnosing osteoarthritis in a feline
WO2009151634A1 (en) * 2008-06-12 2009-12-17 The Board Of Trustees Of The Leland Stanford Junior University Complement inhibitory agents as therapeutics in posttraumatic and degenerative arthritis
DK3424953T3 (en) 2011-06-06 2020-11-02 Novo Nordisk As Terapeutiske antistoffer
EP2994488B1 (en) * 2013-05-08 2022-07-13 Novo Nordisk A/S Use of c5ar antagonists
US11918624B2 (en) 2020-06-10 2024-03-05 Kelsius Laboratories LLC Therapeutic composition for use in the treatment of COVID-19 and other cytokine storm associated disorders
CN114594780B (zh) * 2022-01-24 2024-11-12 国家康复辅具研究中心 主动型假脚控制方法和系统以及终端滑模控制器

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692511A (en) * 1984-07-03 1987-09-08 Immunetech Pharmaceuticals Peptide antagonists for the C5a anaphylatoxin
US5643872A (en) * 1989-10-23 1997-07-01 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
US5807824A (en) * 1993-12-06 1998-09-15 Ciba-Geigy Corporation C5A receptor antagonists having substantially no agonist activity
MX9603773A (es) * 1994-03-03 1997-07-31 Genentech Inc Anticuerpos monoclonales anti-interleucina-8 para el tratamiento de trastornos inflamatorios.
US5614370A (en) * 1994-03-18 1997-03-25 Merck & Co., Inc. Assay to identify human C5a antagonists and agonists
US5789542A (en) * 1994-04-22 1998-08-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Amphipathic peptides
CA2198706C (en) * 1994-09-23 2008-07-08 Yi Wang Methods for the treatment of inflammatory joint disease
US5935796A (en) * 1995-06-30 1999-08-10 The University Of Melbourne Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown
US6013764A (en) * 1996-07-17 2000-01-11 Ortho Pharmaceutical Corp. Liquid phase peptide synthesis of KL-4 pulmonary surfactant
SE9702002D0 (sv) * 1997-05-28 1997-05-28 Astra Pharma Prod Novel compounds
JP3626206B2 (ja) * 1997-06-13 2005-03-02 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ Ｓｍａｄ６及びその使用
AUPO755097A0 (en) * 1997-06-25 1997-07-17 University Of Queensland, The Receptor agonist and antagonist
SE9702651D0 (sv) * 1997-07-09 1997-07-09 Astra Pharma Prod Novel compounds
US5916898A (en) * 1997-10-24 1999-06-29 Zeneca Limited Phenanthroline derivatives
US7410995B1 (en) * 1998-08-14 2008-08-12 Gpi Nil Holdings Inc. N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders
AUPR833401A0 (en) * 2001-10-17 2001-11-08 University Of Queensland, The G protein-coupled receptor antagonists
AUPS160602A0 (en) * 2002-04-08 2002-05-16 University Of Queensland, The Therapeutic method
AU2002952086A0 (en) * 2002-10-16 2002-11-07 The University Of Queensland Treatment of osteoarthritis
CA2542507C (en) * 2002-10-16 2013-04-16 The University Of Queensland Treatment of inflammatory bowel disease
AU2002952129A0 (en) * 2002-10-17 2002-10-31 The University Of Queensland Treatment of hypersensitivity conditions
AU2003902586A0 (en) * 2003-05-26 2003-06-12 The University Of Queensland Treatment of burns
AU2003902743A0 (en) * 2003-06-02 2003-06-19 Promics Pty Limited Process for the preparation of cyclic peptides

Also Published As

Publication number Publication date
CA2542513A1 (en) 2004-04-29
EP1575606A1 (en) 2005-09-21
JP2006505555A (ja) 2006-02-16
EP1575606A4 (en) 2010-03-31
AU2003269609A1 (en) 2004-05-04
AU2003269609B2 (en) 2008-11-20
JP2011241224A (ja) 2011-12-01
US7659246B2 (en) 2010-02-09
US20060234921A1 (en) 2006-10-19
WO2004035079A1 (en) 2004-04-29
US20100267639A1 (en) 2010-10-21

Similar Documents

Publication Publication Date Title
AU2002257936A1 (en) Methods of well treatment
AU2003236991A1 (en) Representations of processes
AU2003230952A1 (en) Treatment of mucositis
AUPS328002A0 (en) Water treatment
AU2003260778A1 (en) Treatment of pipes
AU2002952086A0 (en) Treatment of osteoarthritis
AU2003268923A1 (en) Treatment of aml
AU2003221005A1 (en) Method of wastewater treatment
AU2003225563A1 (en) Compositions and methods for treatment of osteoarthritis
AU2002952129A0 (en) Treatment of hypersensitivity conditions
AU2003231803A1 (en) Treatment of cancer with mefloquire
AU2003270615A1 (en) Treatment of steatosis using hyperthermia
AU2002951011A0 (en) Water treatment process
AU2003248584A1 (en) Method of treating osteoarthritis
AU2002951913A0 (en) Method of treatment
AU2003207315A1 (en) Treatment of muscle damage
AU2003274359A1 (en) Treatment of fluids
AU2003208809A1 (en) Treatment of neuroblastoma
AU2003902586A0 (en) Treatment of burns
AU2003272327A1 (en) Methods of bone healing
AU2003245211A1 (en) Treatment of osteoporosis
AU2003266170A1 (en) Treatment of food pieces
AU2003271712A1 (en) Treatment of amm
AUPS219902A0 (en) Methods of treatment
AU2003903858A0 (en) Treatment of chloraminated water